Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C6H11NO6 |
| Molecular Weight | 193.1546 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
InChI
InChIKey=VOIFKEWOFUNPBN-QIUUJYRFSA-N
InChI=1S/C6H11NO6/c7-5(11)4-2(9)1(8)3(10)6(12)13-4/h1-4,6,8-10,12H,(H2,7,11)/t1-,2-,3+,4-,6+/m0/s1
| Molecular Formula | C6H11NO6 |
| Molecular Weight | 193.1546 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Glucuronamide is a hexose related to glucuronic acid. It’s used against fatigue and detoxify the body. Usually this component is used together with others compounds: caffeine and ascorbic acid. The main side effects of these drugs are insomnia and heart palpitations. Glucuronamide can be considered as doping. Glucuronamide is a very efficient agent in HIV+ patients, which can be used early in infection, due to its total absence of toxicity, but can't be stopped
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: http://www.positifs.org/old/traduc/c/c5.htm
Posology: 400 mg of glucuronamide associated to 500mg Vit.C and 50mg caffein
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:43:53 GMT 2025
by
admin
on
Wed Apr 02 08:43:53 GMT 2025
|
| Record UNII |
1Q5MP1Z8HW
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
61914-43-0
Created by
admin on Wed Apr 02 08:43:53 GMT 2025 , Edited by admin on Wed Apr 02 08:43:53 GMT 2025
|
PRIMARY | |||
|
C83734
Created by
admin on Wed Apr 02 08:43:53 GMT 2025 , Edited by admin on Wed Apr 02 08:43:53 GMT 2025
|
PRIMARY | |||
|
C1505
Created by
admin on Wed Apr 02 08:43:53 GMT 2025 , Edited by admin on Wed Apr 02 08:43:53 GMT 2025
|
CONCEPT | Dietary Supplement | ||
|
1Q5MP1Z8HW
Created by
admin on Wed Apr 02 08:43:53 GMT 2025 , Edited by admin on Wed Apr 02 08:43:53 GMT 2025
|
PRIMARY | |||
|
DTXSID1046261
Created by
admin on Wed Apr 02 08:43:53 GMT 2025 , Edited by admin on Wed Apr 02 08:43:53 GMT 2025
|
PRIMARY | |||
|
1309
Created by
admin on Wed Apr 02 08:43:53 GMT 2025 , Edited by admin on Wed Apr 02 08:43:53 GMT 2025
|
PRIMARY | |||
|
GLUCURONAMIDE
Created by
admin on Wed Apr 02 08:43:53 GMT 2025 , Edited by admin on Wed Apr 02 08:43:53 GMT 2025
|
PRIMARY | |||
|
C026317
Created by
admin on Wed Apr 02 08:43:53 GMT 2025 , Edited by admin on Wed Apr 02 08:43:53 GMT 2025
|
PRIMARY | |||
|
100000084208
Created by
admin on Wed Apr 02 08:43:53 GMT 2025 , Edited by admin on Wed Apr 02 08:43:53 GMT 2025
|
PRIMARY | |||
|
SUB07940MIG
Created by
admin on Wed Apr 02 08:43:53 GMT 2025 , Edited by admin on Wed Apr 02 08:43:53 GMT 2025
|
PRIMARY | |||
|
636367
Created by
admin on Wed Apr 02 08:43:53 GMT 2025 , Edited by admin on Wed Apr 02 08:43:53 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107404
Created by
admin on Wed Apr 02 08:43:53 GMT 2025 , Edited by admin on Wed Apr 02 08:43:53 GMT 2025
|
PRIMARY | |||
|
32323
Created by
admin on Wed Apr 02 08:43:53 GMT 2025 , Edited by admin on Wed Apr 02 08:43:53 GMT 2025
|
PRIMARY | |||
|
4320
Created by
admin on Wed Apr 02 08:43:53 GMT 2025 , Edited by admin on Wed Apr 02 08:43:53 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |